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Abstract
Down syndrome (DS, also known as trisomy 21) most often results from chromosomal non-
disjunction during oogenesis. Numerous studies sustain a causal link between global DNA
hypomethylation and genetic instability. It has been suggested that DNA hypomethylation
might affect the structure and dynamics of chromatin regions that are critical for chromo-
some stability and segregation, thus favouring chromosomal nondisjunction during meiosis.
Maternal global DNA hypomethylation has not yet been analyzed as a potential risk factor
for chromosome 21 nondisjunction. This study aimed to asses the risk for DS in association
with maternal global DNA methylation and the impact of endogenous and exogenous fac-
tors that reportedly influence DNAmethylation status. Global DNA methylation was ana-
lyzed in peripheral blood lymphocytes by quantifying LINE-1 methylation using the
MethyLight method. Levels of global DNAmethylation were significantly lower among moth-
ers of children with maternally derived trisomy 21 than among control mothers (P = 0.000).
The combination ofMTHFR C677T genotype and diet significantly influenced global DNA
methylation (R2 = 4.5%, P = 0.046). The lowest values of global DNA methylation were ob-
served in mothers withMTHFR 677 CT+TT genotype and low dietary folate. Although our
findings revealed an association between maternal global DNA hypomethylation and triso-
my 21 of maternal origin, further progress and final conclusions regarding the role of global
DNA methylation and the occurrence of trisomy 21 are facing major challenges.
Introduction
DNAmethylation is one of the most important epigenetic factors in the regulation of gene ex-
pression. It is required in many processes, such as embryogenesis, gametogenesis, and the si-
lencing of repetitive DNA elements [1]. The patterns of DNA methylation are non-random,
well regulated, and tissue-specific [2]. DNA methylation in white blood cells (WBC) may be
influenced by certain factors, which include demographics (age, sex, race), behavioural risk fac-
tors [cigarette smoking, alcohol intake, body mass index (BMI), and dietary habits such as fo-
late intake], and polymorphism of the methylenetetrahydrofolate reductase gene (MTHFR
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C677T) [3–10]. Aberrant methylation patterns, including global DNA hypomethylation and
gene-specific hypermethylation, have been reported to alter gene expression and have been im-
plicated in various human diseases [11–14]. Gene-specific hypermethylation is linked to gene
silencing, while global hypomethylation of DNA has been reported to contribute to chromo-
some instability and to alter gene expression [15,16]. Global DNA hypomethylation occurs
mainly at heavily methylated noncoding regions of DNA, particularly repeat sequences and
transposable elements [13,14]. It was reported that methylation of Long Interspersed Nucleo-
tide Element-1 (LINE-1) correlates with global DNA methylation, and that the methylation
status of LINE-1 in WBC is a potential biomarker in a variety of diseases [8,17–19]. LINE-1 is
the largest member of the LINE family and constitutes 17% of the human genome; it has been
estimated that more than 500,000 LINE-1 elements are dispersed throughout the genome [20].
Recently, the MethyLight methodology was developed and validated for quantification of
LINE-1 methylation [17].
Down syndrome (DS), or trisomy 21 (MIM 190685), is one of the most common chromo-
somal abnormalities, with a prevalence of 1 in 1000 live births [21]. Trisomy 21 usually results
from chromosomal nondisjunction during oogenesis (90%-95%), particularly during the first
meiotic division (70%-85%) [22,23]. It has been suggested that DNA hypomethylation might
affect chromatin structure in subtelomeric and pericentromeric regions that are critical for
chromosome stability and segregation, thus favouring chromosome 21 nondisjunction during
meiosis [24]. In addition, maternal age and altered genetic recombination, which are well es-
tablished risk factors for DS, have been linked with altered DNAmethylation patterns [25–29].
However, global DNAmethylation has not yet been quantified in any population of mothers of
children with DS.
The aims of the present study were to asses (i) the risk for DS in association with maternal
global DNAmethylation of LINE-1 in WBC, and (ii) the impact of endogenous and exogenous
factors that reportedly influence DNA methylation status. Those factors wereMTHFR C677T
polymorphism, maternal age, BMI, dietary intake of folate, cigarette smoking, alcohol intake,
and medication use.
Materials and Methods
Study population
A total of 94 mothers of children with DS with full trisomy 21 were enrolled in this study. The
karyotypes of the parents were confirmed as normal. Only mothers of children with maternally
derived trisomy 21 were included. The control group consisted of mothers of healthy children
with no personal or family history of DS or other aneuploidy (n = 100). Blood samples of cases
and control mothers were collected in collaboration with DS associations from larger cities in
Croatia (Rijeka, Zagreb, Pula, Zadar, Split, Karlovac, Čakovec, and Osijek). The control and
case groups were age-matched and of the same ethnicity (white). Maternal age was calculated
as the age of the mother at the time of sampling. All study protocols were reviewed by the Eth-
ics Committee of the School of Medicine, University of Rijeka. All participants provided writ-
ten informed consent prior to participation in the study. Before the sampling, study
participants were asked to complete a specially created questionnaire that included demo-
graphic data, weight and height (for BMI calculation), intake of folate-rich foods, cigarette
smoking, alcohol intake, and medication use. The questionnaire was adapted from a food fre-
quency questionnaire validated for the Croatian women [30].
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Genetic analysis
Genomic DNA was isolated from frozen blood samples using the QIAamp DNA Blood Flexi-
Gene DNA Kit (Qiagen, Hilden, Germany). The parental origin of trisomy 21 was determined
as previously described [22]. Genomic DNA was quantified using a spectrophotometer accord-
ing to the manufacturer's instructions (BioMateTM3, Thermo Electron Corporation, USA).
TheMTHFR C677T polymorphism analysis was performed using polymerase chain reaction–
restriction fragment length polymorphism (PCR-RFLP) [31].
Using the EpiTec Bisulfite Kit (Qiagen, Hilden, Germany), 500 ng of genomic DNA under-
went sodium bisulphite modification. The converted DNA was resuspended in 30 μl TE buffer.
Bisulphite-treated DNA was diluted 10× and 8.18 μl was used for each real-time PCR reaction.
All samples were stored at -20°C until they were ready for analysis. All methylation analysis
was performed within 1 month after the bisulphite modification of the DNA.
Global DNA methylation was analysed by quantifying LINE-1 methylation using Methy-
Light methodology [17]. The performance characteristics of the MethyLight assay, including
precision and reproducibility have been well described [8,17,32–34]. The PCR primers and
probes for LINE-1 (Genebank Accession Number X58 075) are presented in Table 1. The
LINE-1 primers lack CpG sites; therefore, two specific TaqMan MGB probes (corresponding
to the methylated and unmethylated LINE-1 sequence after bisulphite treatment) were used in
real-time PCR (Applied Biosystems, Forest City, CA, USA). The VIC-labelled probe hybridizes
to the sequence of the methylated LINE-1 allele, and the FAM-labelled probe hybridizes to the
sequence of the unmethylated LINE-1 allele. The probe sequences cover multiple CpG sites
within the LINE-1 repetitive sequences, which reflect genome-wide methylation density. PCR
reactions were performed with a final reaction volume of 25 μl in sealed 96-well plates on the
ABI 7500 Real-Time PCR System (Applied Biosystems, Forest City, CA, USA). PCR reactions
contained 12.5 μl TaqMan Universal Master Mix, 2.5 μM of each of the LINE-1 primers, and
150 nM of each TaqMan MGB probe. The amount of resulting fluorescence detected, either
VIC or FAM, is directly proportional to the amount of PCR product generated from methylat-
ed or unmethylated DNA, respectively [32]. This experimental design allowed the analysis of
only fully methylated and unmethylated alleles in the LINE-1 repetitive element. If partial
methylation occurs at the level of probe discrimination, the sequence derived after bisulphite
conversion is not recognized by either of the two probes. For normalization of DNA input, an
Alu-based real-time PCR control reaction was performed in parallel with each LINE-1 real-
time PCR reaction, as previously described [17]. Primers and probes for Alu sequences
(ALU-C4) (Applied Biosystems, Forest City, CA, USA) are shown in Table 1. ALU-C4 PCR re-
actions contained 12.5 μl TaqMan Universal Master Mix, 0.3 μM of each of the primers, and
100 nM of TaqMan MGB probe corresponding to the ALU-C4 sequence after bisulphite
Table 1. Real-time PCR primers and probes.
Primer Primer sequence
Line-1 F 50TTATTAGGGAGTGTTAGATAGTGGG30
Line-1 R 50CCTCTAAACCAAATATAAAAT ATAATCTC30;
ALU-C4 F 5’GGTTAGGTATAGTGGTTTATATTTGTAATTTTAGTA3’
ALU-C4 R 5’ATTAACTAAACTAATCTTAAACTCCTAACCTCA3’
Probe Probe sequence
Line-1 met VIC–TACTTCGACTCGCGCACGATA-MBG3'
Line-1 unmet 6FAM–CCTACTTCAACTCACACA-MBG3'
ALU-C4 6FAM-CCTACCTTAACCTCCC-MGB3'
doi:10.1371/journal.pone.0127423.t001
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treatment. The cycle conditions for the LINE-1 and ALU-C4 assay were as previously described
[8,17]. Real-time PCR was performed in duplicate for each sample.
The MethyLight data specific for methylated repetitive elements were expressed as percent
of methylated reference (PMR) values, and the levels of unmethylated repetitive elements were
expressed as percent of unmethylated reference (PUR) values [17,32]. These values were calcu-
lated as previously described, with the following changes. The standard curve was established
using EpiTect Methylated Control DNA and EpiTect Unmethylated Control DNA (Qiagen,
Hilden, Germany), which were mixed to contain 100%, 90%, 75%, 50%, 25%, 10%, and 0%
methylated DNA. The mixtures of methylated and unmethylated DNA were diluted 10x and
run in each real-time PCR plate with experimental samples. After PCR amplification, data
were read using the SDS 1.4.0 software (Applied Biosystems, Forest City, CA, USA). Global
DNAmethylation was determined using the formula for absolute quantification, which was
modified in the sense that PMR and PUR values were incorporated, because those are corrected
in relation to the DNA input. Therefore, the final percentage of global DNAmethylation was
calculated according to the formula PMR/(PMR+PUR) × 100.
Analysis of the impact of endogenous and exogenous factors on global
DNAmethylation
Factors included in the analysis were maternal age and BMI as continuous variables, and ciga-
rette smoking, alcohol intake, and medication use as categorical variables. Maternal age was
also studied as a categorical variable; two age groups were defined: 35 years of age or younger
(35 years) and older than 35 years of age (>35 years). This age limit was set because the risk
of having a child with DS after 35 years of age rises proportionately with maternal age [26,35].
Because of the complex relationships between genetic variants in the folate pathway and diet,
the analysis also included the variable “MTHFR C677T genotype/diet”, which represented a
combination ofMTHFR C677T polymorphism and dietary folate intake (rich or poor)
[9,10,36,37]. Folate-rich diet implied that mothers consumed at least three folate-rich foods
(green leafy vegetables, legumes, liver of veal, fruit, corn flakes, muesli), at least 2–3 times each
week. Any lower intake was defined as a low-folate diet. Mothers who consumed one glass of
wine or one glass of beer or one small glass of strong alcohol drink, at least one time per week
or more often, were defined as consumers. Those who currently smoked cigarettes daily or oc-
casionally were clasified as smokers. Stepwise regression was first performed in all studied
mothers (cases and controls together; n = 184), and then in each group separately.
Statistical analysis
The χ2 test and Fisher's test were used to assess deviations from Hardy–Weinberg equilibrium
and to compare allelic and genotypic frequencies between groups. LINE-1 methylation values
for cases and controls were compared using a Mann–Whitney U test. The statistical power of
97% was calculated according to Lehmann [38]. Multivariable logistic regression was used to
determine the odds ratio and 95% confidence interval for the association between LINE-1
methylation and case-control status while adjusting for BMI and dietary folate intake. The
stepwise regression analysis was used to assess the influence of endogenous and exogenous fac-
tors, includingMTHFR C677T polymorphism, age, BMI, dietary intake of folate, smoking, al-
cohol intake, and medication use, as predictors of global DNA methylation. Kruskal–Wallis
ANOVA was used to establish the association of continuous variables with skewed distribution
and global DNA methylation. P<0.05 was the defined threshold for statistical significance. Sta-
tistica for Windows 10.0 (StatSoft, Tulsa, OK, USA) was used to analyse the data.
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Results
The study included 94 mothers of children with DS of maternal origin and 100 mothers of
healthy children with no personal or family history of DS or other aneuploidy. General charac-
teristics of study participants are presented in Table 2. Complete data from questionnaires was
available for 95.7% of control and 94% of case mothers; maternal age was the only available pa-
rameter for the remaining mothers (controls: n = 4 and cases: n = 6). BMI was significantly
higher among case mothers than among control mothers. The frequency of folate-rich food in-
take was significantly lower in mothers of children with DS than in control mothers (P<0.001;
Table 2).
Genotypes and allelic distribution ofMTHFR C677T in cases and controls were in agree-
ment with Hardy–Weinberg equilibrium. The frequencies ofMTHFR C677T genotypes and al-
leles did not not differ significantly between those two groups (P>0.05; Table 3).
Global DNA methylation
Global DNAmethylation was significantly lower in mothers of children with DS (median:
95.45%; min-max: 79.13%-99.90%) than in control mothers (median: 97.99%; min-max:
88.61%-99.78%) (P = 0.000; Fig 1). After adjusting for BMI and dietary folate intake, LINE-1
methylation was significantly lower among mothers of children with DS (OR = 0.83, 95% CI:
0.733–0.928, P = 0.001).
The impact of endogenous and exogenous factors on global DNA
methylation
Among all studied mothers, group affiliation,MTHFR C677T genotype/diet combination and
age group were identified as statistically significant predictors of global DNAmethylation val-
ues (Table 4). Case mothers were significantly more likely to have lower levels of global DNA
methylation compared to control mothers (β = 0.256; R2 = 0.102; P = 0.000). CC genotype in
Table 2. General characteristics of mothers of children with DS and control mothers of healthy
children.
Cases Controls P
Age, years* 39.5 [18–64] 39 [23–65] 0.942
BMI* 25.01 [17.19–39.68] 23.48 [18.07–34.60] 0.007
Diet: N** (%)
Folate-rich 37 (41) 66 (70) 0.000
Low-folate 53 (59) 28 (30)
Smoking: N** (%)
No 60 (67) 62 (66) 0.957
Yes 30 (33) 32 (34)
Alcohol intake: N** (%)
No 69 (77) 78 (83) 0.188
Yes 21 (23) 16 (17)
Medication use: N** (%)
No 85 (94) 83 (88) 0.111
Yes 5 (6) 12)
*Median [min—max]
**Mothers of children with DS (N = 90); control mothers (N = 94)
doi:10.1371/journal.pone.0127423.t002
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combination with a folate-rich diet was significantly associated with higher values of global
DNAmethylation, and the CT+TT genotype and low-folate diet were associated with lower
values (β = 0.207; R2 = 0.032; P = 0.011). Values of global DNA methylation in case mothers as
Table 3. Allelic and genotypic frequencies ofMTHFRC677T polymorphism.
MTHFR C677T Cases* N (%) Controls** N (%) OR (95%CI) P
Genotype
CC 46 (49) 49 (49) Reference
CT 38 (40) 42 (42) 1.04 (0.57–1.88) 0.903
TT 10 (11) 9 (9) 0.84 (0.32–2.27) 0.738
CT+TT 48 (51) 51 (51) 1.00 (0.57–1.75) 0.993
Alelle
C 130 (69) 140 (70) Reference
T 58 (31) 60 (30) 0.96 (0.62–1.48) 0.856
*Mothers of children with DS; N = 94
**Control mothers; N = 100
doi:10.1371/journal.pone.0127423.t003
Fig 1. Global DNAmethylation in mothers of DS children and control mothers
doi:10.1371/journal.pone.0127423.g001
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a function of theMTHFR C677T genotype/diet combination are presented in Table 5. The low-
est values of global DNA methylation were observed in mothers with CT+TT genotype and a
low-folate diet. Mothers>35 years were significantly more likely to have lower levels of global
DNAmethylation compared to mothers35 years (β = -0.164; R2 = 0.026; P = 0.018). Thirty-
one percent of mothers (n = 61) were older than 35 years and 69% (n = 133) of mothers were
younger than 35 years. Mothers>35 years had significantly lower levels of global DNAmethyl-
ation (median: 96,60%; min-max: 79,13%- 99,90%) than mothers35 years (median: 97,81%;
min-max: 90,56%- 99,78%) (P = 0,016).
Among mothers of DS children, 4.5% of variance in global DNA methylation can be pre-
dicted by theMTHFR C677T genotype/diet combination (β = 0.588; R2 = 0.045; P = 0.046).
The lowest values of global DNAmethylation were observed in mothers with CT+TT genotype
and a low-folate diet (Table 6).
Among control mothers, the only statistically significant predictor of global DNA methyla-
tion was maternal age group (β = -0.248; R2 = 0.062; P = 0.016). Thirty-four percent of mothers
(n = 34) were older than 35 years and 66% (n = 66) were younger than 35 years. Mothers>35
years had significantly lower levels of global DNA methylation (median: 97.74%; min-max:
88.61%-99.75%) than mothers35 years (median: 98.82%; min-max: 90.85%-99.78%)
(P = 0.003). Mothers of DS children had significantly lower levels of global DNAmethylation
than control mothers>35 years (P = 0.001) and control mothers35 years (P = 0.000).
Other analysed factors, including cigarette smoking, alcohol intake, medication use and
BMI exhibited no association with methylation status, nether in case (P>0.05) nor in control
mothers (P>0.05).
Table 4. Stepwise regression summary for global DNAmethylation in all studiedmothers.
All mothers (Cases and controls) (N = 184)
Dependent variable Predictor variable β Multiple R2 change P
Global DNA methylation Afﬁliation to a group cases/controls 0.256 0.102 0.000
MTHFR C677T genotype/diet 0.207 0.032 0.011
Age group -0.164 0.026 0.018
Criteria used for independent variable’s entry or removal: F to enter = 4, F to remove = 1.
doi:10.1371/journal.pone.0127423.t004
Table 5. Global DNAmethylation in all studiedmothers depending on the combinationMTHFRC677T
genotype/diet.
All mothers (Cases and controls): N = 184 N (%) Global DNA methylation (%)*
MTHFR C677T genotype/diet
CC/folate rich diet** 53 (29) 97.85 [89.21–99.75]
CT+TT/folate rich diet 50 (27) 96.96 [89.98–99.90]
CC/folate poor diet 35 (19) 96.53 [88.61–99.78]
CT+TT/folate poor diet** 45 (25) 95.94 [79.13–99.77]
*Median [min—max]
**P = 0,031
doi:10.1371/journal.pone.0127423.t005
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Discussion
To the best of our knowledge, this is the first study to quantify and analyse global DNAmethyl-
ation in mothers of children with DS. Our results revealed significantly lower level of LINE-1
methylation, a surrogate marker of global DNAmethylation, in mothers of children with DS
than in mothers of healthy children (95.45% and 97.99%, respectively). The obtained values of
global DNAmethylation were in accordance with other reports and range from 79% to 100%
[8,17,39]. Two strengths of the present study should be emphasised. First, all participants were
of the same ethnicity, which is important because an effect of race on DNAmethylation has
been reported [6]. Second, all trisomy 21 cases were of maternal origin, which allowed us to ex-
plore the real-life effect of DNAmethylation as a maternal risk factor for DS. Namely, the caus-
al link between DNA hypomethylation and genetic instability has been proposed by numerous
previously published studies. DNA hypomethylation has been associated with aneuploidy in
human cancer cell lines, with abnormal chromosomal structures in cells from patients with
immunodeficiency, centromeric instability and facial anomalies syndrome, and with increased
rate of aneuploidy, polyploidy, and chromosomal aberrations in cells treated with the demeth-
ylating agents [15,40–45]. Further, the values of global DNA methylation were associated with
combination of theMTHFR C677T polymorphism and dietary folate intake (MTHFR C677T
genotype/diet). TheMTHFR gene encodes the MTHFR enzyme, which catalyses the conver-
sion of 5,10-methylenetertahydrofolate to 5-methylene tetrahydrofolate, the main donor of
methyl groups for numerous methylation reactions, including DNAmethylation [46].MTHFR
C677T polymorphism reduces enzyme activity by approximately 35% in individuals with the
CT genotype, and by 70% in individuals with the TT genotype [36]. However, increased folate
intake can neutralize the polymorphism’s metabolic impact and restore normal enzyme activity
[37,47]. Moreover, studies that quantitatively measured global DNA methylation in WBC of
healthy persons found that individuals with theMTHFR 677TT genotype and a lower concen-
tration of folate in the blood have significantly lower global DNAmethylation than individuals
with CT or CC genotypes [9,10]. Our results show thatMTHFR C677T genotype/diet combi-
nation was a significant predictor of global DNA methylation variance in mothers of children
with trisomy 21. Although not statistically significant, values of global DNAmethylation in
mothers of DS children were stratified according to the combinationMTHFR C677T geno-
type/diet, wherein the lowest values were observed in mothers with the CT+TT genotype and a
low-folate diet, and the highest levels of global DNAmethylation were observed in mothers
with the CC genotype and a folate-rich diet. Our findings support the initial hypothesis of
James et al. that maternalMTHFR C677T polymorphism may lead to the hypomethylation of
chromosomal regions which are essential for their stability and segregation, and therefore rep-
resent a potential maternal risk factor for chromosome 21 nondisjunction [24]. They were the
Table 6. Global DNAmethylation in mothers of children with DS depending on theMTHFRC677T ge-
notype/diet.
Mothers of children with DS: N = 90 N (%) Global DNA methylation (%)*
MTHFR C677T genotype/diet
CC/folate rich diet 21 (23) 96.42 [90.70–99.73]
CT+TT/folate rich diet 16 (18) 94.72 [90.56–99.90]
CC/folate poor diet 22 (25) 95.09 [91.36–98.95]
CT+TT/folate poor diet 31 (34) 94.30 [79.13–99.48]
*Median [min—max]
P = 0.383
doi:10.1371/journal.pone.0127423.t006
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first who analysedMTHFR C677T polymorphism as a maternal risk factor for trisomy 21, and
found that mothers of children with DS have mildly elevated plasma homocysteine levels and a
2.6-fold increased frequency ofMTHFR C677T polymorphism in one or both alleles. Numer-
ous studies have been conducted to address this issue, as reviewed by Coppede et al [48]. Dis-
crepancies between different reports imply that the relationship between folate metabolism
and chromosome 21 nondisjunction is much more complex, and indicate the importance of
other factors that might affect folate metabolism and modify the maternal risk for trisomy 21,
including but not limited to maternal age and ethnicity, dietary habits, alcohol consumption,
and pregnancy [48]. Based on all of the abovementioned, it is possible to assume that CT+TT
genotype and a low-folate diet could be involved in reducing the values of global DNA methyl-
ation, and may contribute to the genome instability or nondisjunction of chromosome pair 21
during oogenesis. In fact, the global DNA hypomethylation that we observed in mothers of
children with DS may reflect the hypomethylation of centromeric and pericentromeric DNA
regions. Studies have shown that DNA methylation plays an important role in modulating the
structure and dynamics of heterochromatin [49]. The assembly of heterochromatin is likely to
contribute to various chromatin-dependent processes, as well as the functional organization of
centromeres and telomeres [49–53]. The hypomethylation of centromeric and pericentromeric
DNA regions could lead to the reactivation of epigenetically silenced repetitive elements or the
failure of correct kinetochore assembly, microtubule attachment, or sister-chromatid cohesion,
which have been associated with irregular chromosomal separation [52,54–60]. Alteration of
telomere methylation patterns might also compromise chromosomal stability, through telo-
mere-length deregulation and increased homologous recombination [61]. In addition, DNA
methylation may be one factor that affects the recombination pattern between homologues,
which (aside from maternal age) is also a well-established risk factor for chromosome 21 non-
disjunction [25–28]. It would be interesting to determine whether the global DNA hypomethy-
lation observed in mothers of DS children might have altered recombination pattern, thus
favouring the improper segregation of chromosome 21. Although recombination pattern was
not established in our case mothers, the relationship between DNA methylation status and re-
combination pattern certainly represents a promising subject that will be investigated in our
future studies.
The age-dependent effect on DNAmethylation has been intensively investigated, and it has
been suggested that global DNAmethylation reduces with increased age [29]. The mechanism
underlying DNA hypomethylation is still unclear; however, several factors may trigger and
contribute to the loss of genomic methylation, including the activity and expression of DNA
methyltransferase, the status of one-carbon metabolism, and the integrity of the genome [62].
Therefore, DNA hypomethylation that occurs during normal ageing appears to be a possible
risk factor contributing to the development of age-related human diseases, including cancer,
atherosclerosis, Alzheimer’s disease, psychiatric disorders, and autoimmune pathologies [11–
14,29]. However, determinants of blood DNA methylation in repetitive elements in healthy in-
dividuals are still largely unexplored, and inconsistent patterns have been reported because of
the challenges of interpreting results from different assays and from different sources of DNA.
All studies investigating ageing and Alu methylation support a lower level of DNA methylation
of this repetitive element with increasing age [4,5]. In contrast, only one study found a correla-
tion between lower levels of LINE-1 methylation and increasing age, while most studies did not
report an age-dependent effect on blood LINE-1 methylation [4,5]. In our study, LINE-1 meth-
ylation did not correlate significantly with maternal age in either of studied groups. However, it
is worth noting that control mothers older than 35 years of age exhibited significantly lower
levels of global DNAmethylation than mothers younger than 35 years of age. This finding im-
plies that advanced maternal age is a contributing factor for global DNA hypomethylation.
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However, global DNAmethylation in mothers of DS children was significantly lower, even
compared with the group of control mothers older than 35 years of age. Therefore, it can be as-
sumed that, in mothers of children with trisomy 21 of maternal origin, global DNA hypo-
methylation is caused by numerous factors, including genetic factors (MTHFR 677 CT+TT),
low-folate diet, and advanced age.
Regarding the other factors analysed, cigarette smoking, alcohol intake and BMI exhibited
no association with LINE-1 methylation status in WBC, which is in accordance with other re-
ports [4–6,63]. Although few studies reported significant associations between LINE-1 methyl-
ation and BMI, the direction of change is not consistent [64,65]. The effect of medications on
global DNAmethylation was also not statistically significant. Only 6% of case mothers and
12% of control mothers were taking medications that belonged to several different therapeutic
groups. At the moment we cannot discuss the association between certain medications and
global DNAmethylation.
In conclusion, our results revealed significantly lower levels of global DNAmethylation in
mothers of DS children than in mothers of healthy children. Global DNA hypomethylation is
significantly associated withMTHFR 677 CT+TT genotype and low dietary folate in combina-
tion, as well as with ageing. Some limitations in our study should be considered. Global DNA
methylation values were not measured during oogenesis, when changes in methylation status
would be expected to have the greatest effect. Unfortunately, this information is essentially im-
possible to obtain, since oogenesis begins during embryonic development of the mother. How-
ever, determination of global DNA methylation status may have identified women who were
persistently affected by the same exogenous and particularly endogenous factors which lead to
global DNA hypomethylation. Based on numerous reports about the association between glob-
al DNA hypomethylation and genome instability it could be presumed that maternal global
DNA hypomethylation might be involved in chromosome 21 nondisjunction. More extensive
work should be done to give the answer to this question.
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